Anzeige
Mehr »
Login
Montag, 12.04.2021 Börsentäglich über 12.000 News von 660 internationalen Medien
InnoCan Pharma: Was steckt dahinter? Strong Buy!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PUSM ISIN: SE0013121340 Ticker-Symbol: MB8A 
Frankfurt
12.04.21
08:09 Uhr
0,578 Euro
0,000
0,00 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
MOBERG PHARMA AB Chart 1 Jahr
5-Tage-Chart
MOBERG PHARMA AB 5-Tage-Chart

Aktuelle News zur MOBERG PHARMA Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
10.02.MOBERG PHARMA: OncoZenge has been approved for listing on Nasdaq First North Growth Market1
MOBERG PHARMA Aktie jetzt für 0€ handeln
08.02.MOBERG PHARMA: Correction regarding ISIN code for the share in the prospectus-
08.02.MOBERG PHARMA: OncoZenge has obtained a conditional approval for listing on Nasdaq First North Growth Market and publishes prospectus1
03.02.XFRA CAPITAL ADJUSTMENT INFORMATION - 03.02.2021519CAPITAL ADJUSTMENT INFORMATION - 03.02.2021:Das Instrument 2INV DE000A2YN801 4BASEBIO AG NA O.N. EQUITY wird ex Kapitalmassnahme gehandelt am 03.02.2021 The instrument 2INV DE000A2YN801 4BASEBIO AG...
► Artikel lesen
29.01.MOBERG PHARMA: Announcement of terms for the fully guaranteed rights issue in OncoZenge, timetable for the listing and record date for Lex Asea1
14.01. Nasdaq Stockholm AB: Delisting of paid subscription units in Moberg Pharma AB (5/21)213The paid subscription units in Moberg Pharma AB will be delisted. Last trading day for MOB BTUwill be on January 18, 2021. Instrument: Paid subscription units -------------------------------------- Short...
► Artikel lesen
14.01.Moberg Pharma announces the last day of trading in BTU and the first trading day in warrants1
07.01.MOBERG PHARMA: OncoZenge announces issue of European Patent related to BupiZenge-
23.12.20Moberg Pharma's rights issue of MSEK 150 is fully subscribed and no issue guarantees have been used-
11.12.20MOBERG PHARMA: OncoZenge raises MSEK 10 ahead of spin-off and separate listing-
04.12.20Nasdaq Stockholm AB: Listing of unit rights and paid subscription units of Moberg Pharma AB (publ) (185/20)253With effect from 12/7/2020, the unit rights in Moberg Pharma AB (publ) will be traded on the list for Equity rights. Trading will continue up until and including 12/17/2020. Instrument: Unit...
► Artikel lesen
03.12.20Moberg Pharma publishes prospectus relating to the rights issue1
03.12.20MOBERG PHARMA: Correction of press release from 27 November 2020 regarding publication of final terms for the rights issue2
01.12.20Bulletin from Moberg Pharma's Extraordinary General Meeting on December 1[st], 20202
01.12.20XFRA CAPITAL ADJUSTMENT INFORMATION - 01.12.2020332CAPITAL ADJUSTMENT INFORMATION - 01.12.2020:Das Instrument SUX US87162W1009 SYNNEX CORP. DL -,001 EQUITY wird ex Kapitalmassnahme gehandelt am 01.12.2020 The instrument SUX US87162W1009 SYNNEX CORP....
► Artikel lesen
30.11.20Moberg Pharma obtains positive decision from the Swedish Tax Agency regarding the Lex Asea distribution of the shares in OncoZenge1
30.11.20New number of shares and votes in Moberg Pharma AB (publ)-
27.11.20Moberg Pharma publishes audited interim report for the period July 2019 - September 20201
27.11.20Moberg Pharma announces the final terms of the fully guaranteed rights issue1
23.11.20ONCOZENGE AB: Invitation to market update in Moberg Pharma on November 25[th]1
Seite:  Weiter >>
29 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1